Concepedia

Luc Dasnois

LD

Statistics

Publications

3

Citations

121

H-Index

3

Active since

2001

Affiliations

UCLouvain(Current)

Corixa Corporation

Luc Dasnois is an author at UCLouvain specializing in immunology, medicine, and drug discovery.

Top concepts

Publications per year

2001–2006

3

Publications

3

<i>N</i>-Succinyl-(β-alanyl-<scp>l</scp>-leucyl-<scp>l</scp>-alanyl-<scp>l</scp>-leucyl)doxorubicin:  An Extracellularly Tumor-Activated Prodrug Devoid of Intravenous Acute Toxicity

Anne-Marie Fernandez, Kim Van derpoorten, Luc Dasnois et al. · Journal of Medicinal Chemistry · 2001 · 76 citations

, , +19

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.

Vincent Dubois, Luc Dasnois, Karim Lebtahi et al. · PubMed · 2002 · 34 citations

, , +18

Thimet oligopeptidase (EC 3.4.24.15) activates CPI-0004Na, an extracellularly tumour-activated prodrug of doxorubicin

Vincent Dubois, Matthew Nieder, Françoise Collot et al. · European Journal of Cancer · 2006 · 11 citations

, , +9

1–3 of 3